New Treatment for Uterine Fibroids
August 31, 2022
Fibroids are benign muscle cells, and they can grow as large as a melon and be quite painful. A new procedure called Acessa, is a minimally invasive, laparoscopic method, using radio-frequency ablation to help treat the condition.
According to Latasha N. Murphy, M.D., a gynecologist and surgeon in The Gynecology Center at Mercy, it's an outpatient treatment that involves small abdominal incisions.
"It's a new procedure where we can look at the fibroids and at the same time, use ultrasound to individually treat the fibroid while keeping the thermal energy away from the uterine tissue," Dr. Murphy said.
Which means surrounding uterine tissue is not injured. Dr. Murphy added that women typically experience minimal discomfort after the procedure and return to work in four to five days.
View Dr. Murphy's interview about Acessa for uterine fibroids.
About Mercy
Founded in 1874 in Downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed, acute care, university-affiliated teaching hospital. Mercy has been recognized as a high-performing Maryland hospital (U.S. News & World Report); has achieved an overall 5-Star quality, safety, and patient experience rating (Centers for Medicare and Medicaid Services); is A-rated for Hospital Safety (Leapfrog Hospital Safety Grade); and is certified by the American Nurses Credentialing Center as a Magnet™ hospital. Mercy Health Services is a not-for-profit health system and the parent company of Mercy Medical Center and Mercy Personal Physicians.
Media Contact
Dan Collins, Senior Director of Media Relations
Office: 410-332-9714
Cell: 410-375-7342
Email: dcollins@mdmercy.com